Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Indian Journal of Endocrinology and Metabolism|August 16, 2023
One-Year follow-up of 50 Rural Underprivileged Type 1 Diabetes Children on Insulin Pump Therapy: Breaking Socio-Economic Barriers in Diabetes TechnologiesKrishnan Swaminathan
Indian Journal of Pharmacology|June 13, 2015
Proton pump inhibitor-induced hypomagnesemic hypoparathyroidismKrishnan Swaminathan
Indian Journal of Pharmacology|April 2, 2011
A hidden history of heartburn: The milk-alkali syndromeKrishnan Swaminathan
Journal of the Indian Medical Association|October 3, 2012
The role of general physician in managing diabetes with self monitoring of blood glucoseKrishnan Swaminathan
The Journal of the Association of Physicians of India|October 22, 2016
Dengue Outbreak 2012: Geo Mapping and Snapshot of Clinical Course from a Tertiary Referral Center in South IndiaGanesh Veerasekar, Krishnan Swaminathan
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 2, 2020
Outcomes of parathyroid gland identification and autotransplantation during total thyroidectomyShivprakash Mehta, Muthuswamy Dhiwakar, Krishnan Swaminathan
Indian Journal of Endocrinology and Metabolism|June 5, 2019
Breaking Socioeconomic Barriers in Diabetes Technologies: Outcomes of a Pilot Insulin Pump Programme for the Underprivileged in Rural IndiaKrishnan Swaminathan, Vinaykumar Mukhekar, Ohad Cohen
Trends in Endocrinology and Metabolism: TEM|October 21, 2020
Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular DiseaseGanesan Velmurugan, Vasudevan Dinakaran, Jeyaprakash Rajendhran, et al.
Chemico-Biological Interactions|December 14, 2024
Host-microbiota interplay in arsenic metabolism: Implications on host glucose homeostasisDinakaran Vasudevan, Buvaneswari Gajendhran, Krishnan Swaminathan, et al.
Indian Journal of Pharmacology|June 25, 2021
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational studyJithin Chacko, Shankar Dhandapani, Vidhya Jahagiridhar, et al.
Pageof 3